CoMind
PrivateLast Round
Series A
Extension
Oct 20, 2025
Total Funding Raised
$102.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CoMind is a neurotechnology company that develops non-invasive brain-computer interfaces and optical neuromonitoring devices designed to monitor neurological parameters and improve patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoMind Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CoMind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 20, 2025 | ||||
| Series A | Nov 1, 2023 | ||||
| Grant | Jan 6, 2022 |
Key People
Founding team and executive leadership
CoMind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Series A Extension |
| LocalGlobe | Series A Extension |
| Latitude Ventures | Series A Extension |
| Angelini Ventures | Series A Extension, Series A |
| Phoenix Court Group | Series A Extension, Seed |
| LocalGlobe | Series A Extension |
| Thiel Fellowship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Neuromonitoring tech in clinical trials, developing FDA software.
- Mar 30, 2026
First two papers published in Neurophotonics journal.
CoMind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CoMind's valuation, stock price, and market status.